Literature DB >> 16929312

Tuning silence: conditional systems for RNA interference.

Maciej Wiznerowicz1, Jolanta Szulc, Didier Trono.   

Abstract

RNA interference (RNAi) has emerged as a powerful tool to downregulate the expression of specific genes. Drug-inducible systems allowing for conditional RNAi that offer the unique potential to modulate expression of virtually any endogenous gene in the cell have been recently developed. Their applications are very broad, ranging from basic studies of gene function to translational research including modeling of human diseases, analysis of potential side effects of candidate drugs, testing of gene-based therapies and loss-of-function screens. Here we summarize the state of the art of systems allowing for drug-controllable knockdown, and provide a description of their current and future applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16929312     DOI: 10.1038/nmeth914

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  41 in total

1.  Silencing of IkBβ mRNA causes disruption of mitochondrial retrograde signaling and suppression of tumor growth in vivo.

Authors:  Weigang Tang; Anindya Roy Chowdhury; Manti Guha; Li Huang; Thomas Van Winkle; Anil K Rustgi; Narayan G Avadhani
Journal:  Carcinogenesis       Date:  2012-05-27       Impact factor: 4.944

2.  A Synthetic Gene Circuit for Self-Regulating Delivery of Biologic Drugs in Engineered Tissues.

Authors:  Lara Pferdehirt; Alison K Ross; Jonathan M Brunger; Farshid Guilak
Journal:  Tissue Eng Part A       Date:  2019-05       Impact factor: 3.845

Review 3.  Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?

Authors:  Dirk Grimm; Mark A Kay
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

4.  Light-dependent RNA interference with nucleobase-caged siRNAs.

Authors:  Vera Mikat; Alexander Heckel
Journal:  RNA       Date:  2007-10-19       Impact factor: 4.942

5.  Multipurpose modular lentiviral vectors for RNA interference and transgene expression.

Authors:  Venu Kesireddy; Peter F M van der Ven; Dieter O Fürst
Journal:  Mol Biol Rep       Date:  2009-10-02       Impact factor: 2.316

6.  Tissue-engineered cartilage with inducible and tunable immunomodulatory properties.

Authors:  Katherine A Glass; Jarrett M Link; Jonathan M Brunger; Franklin T Moutos; Charles A Gersbach; Farshid Guilak
Journal:  Biomaterials       Date:  2014-04-22       Impact factor: 12.479

7.  Tissue-specific and reversible RNA interference in transgenic mice.

Authors:  Ross A Dickins; Katherine McJunkin; Eva Hernando; Prem K Premsrirut; Valery Krizhanovsky; Darren J Burgess; Sang Yong Kim; Carlos Cordon-Cardo; Lars Zender; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

Review 8.  Automated microscopy for high-content RNAi screening.

Authors:  Christian Conrad; Daniel W Gerlich
Journal:  J Cell Biol       Date:  2010-02-22       Impact factor: 10.539

9.  Heritable and lineage-specific gene knockdown in zebrafish embryo.

Authors:  Mei Dong; Yan-Fang Fu; Ting-Ting Du; Chang-Bin Jing; Chun-Tang Fu; Yi Chen; Yi Jin; Min Deng; Ting Xi Liu
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

10.  A versatile viral system for expression and depletion of proteins in mammalian cells.

Authors:  Eric Campeau; Victoria E Ruhl; Francis Rodier; Corey L Smith; Brittany L Rahmberg; Jill O Fuss; Judith Campisi; Paul Yaswen; Priscilla K Cooper; Paul D Kaufman
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.